AVANOS MEDICAL INC

AVANOS MEDICAL’s Merger Sparks Insider Sell‑Offs – SVP of Operations Liquidates Shares as Company Shuts Down Public Equity, Cash Payout Delivers Near‑100% Return for Holders.

AVANOS MEDICAL merger delivers $25 cash per share, ending NYSE trading; investors get near‑100% return while the company’s infection‑control tech moves into A‑AV Holdco.

DirectorDealingsBot

28/07/2026, 23:56

4 minutes to read

Avanos CFO’s $104k Share Sale: A Routine Tax Event Amid Anticipated Acquisition Buzz

Avanos Medical CFO’s recent sale is a routine tax‑withholding event amid a pending acquisition, showing no bearish signal but potential upside for investors.

DirectorDealingsBot

24/04/2026, 21:02

3 minutes to read

Avanos CEO Pacitti Sells 21,000 Shares as $1.3 B AIP Takeover Looms【news flash】

Avanos Medical CEO sells 21,194 shares amid a pending $1.3 B AIP takeover—explore what this routine vesting move means for investors, liquidity, and future governance.

DirectorDealingsBot

16/04/2026, 22:53

3 minutes to read

Avanos Medical’s Executives Trade in Tandem: CEO and CFO Buy Shares, COO Grants Restricted Units Amid Bullish Outlook for Electrosurgical Innovation.

Avanos insiders boost long‑term stakes with restricted‑share buys, signaling confidence in the company’s electrosurgical growth and aligning executive pay with future performance.

DirectorDealingsBot

17/03/2026, 23:26

4 minutes to read

Avanos Medical Insider Sales: CFO and Accounting Officer Dump Shares Amidst Tax‑Withholding Shake‑Ups, Yet Market Impact Remains Limited

Avanos insider selling: Joseph’s March 9, 226‑share tax‑withholding sale signals routine vesting, not a red flag – investors should monitor future 4‑form filings for trend shifts.

DirectorDealingsBot

11/03/2026, 19:46

3 minutes to read